查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1577306

生醫冰箱與冷凍櫃市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Biomedical Refrigerators and Freezers Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 87 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球生物醫學冰箱和冰櫃市場價值約為 37 億美元，在老年人口不斷成長的推動下，預計 2024 年至 2032 年複合年成長率為 5.3%。

世界衛生組織 (WHO) 預測，到 2030 年，全球六分之一的人將年齡在 60 歲或以上。隨著全球人口老化，針對老年人的醫療服務、藥品和生物製藥的需求不斷增加。這一人群通常需要全面的醫療治療，從疫苗和藥物到器官移植，這凸顯了生物醫學冰箱和冰櫃實現最佳儲存和保存的必要性。此外，與年齡相關的疾病和病症的增加推動了老年護理領域的先進研究和開發，擴大了生物醫學領域對頂級儲存解決方案的需求。

技術創新不斷增強生物醫學冰箱和冰櫃的功能。增強的冷卻技術、節能系統以及複雜的溫度監測和控制功能等突破擴大了這些設備的功能和可靠性。此外，生物製藥和器官移植需求的激增推動了市場的發展。生物技術的進步促進了生物製藥的生產，包括疫苗和基因療法，這需要嚴格的溫度調節。同時，器官移植需求的不斷增加凸顯了供體器官可靠儲存的重要性。對生物製藥和器官移植的高度依賴增加了對最先進的生物醫學冷凍系統的需求，推動了市場擴張。

整個生物醫​​學冰箱和冰櫃行業根據產品、最終用途和地區進行分類。

到 2032 年，實驗室冰箱市場預計將達到 16 億美元。隨著全球研究活動的蓬勃發展和實驗室不斷擁抱技術進步，對可靠、高效的冷凍解決方案的需求不斷增加。學術和工業研究資金的增加，加上對精準醫學和生物技術的高度關注，進一步增加了對先進實驗室冷凍設備的需求。此外，卓越的溫度控制、能源效率和直覺的介面等功能的不斷發展滿足了現代實驗室的需求。

2023年，診斷中心部門的估值為14億美元。慢性病發病率的上升以及對及時、精確診斷的需求不斷增加，刺激了對尖端診斷技術和可靠儲存解決方案的需求。此外，對預防性醫療保健和常規健康檢查的日益重視也擴大了診斷中心對這些設備的需求。隨著這些中心的發展和產品範圍的擴大，對專業生物醫學冰箱和冷凍庫的需求將保持強勁。

到2032年，美國生物醫學冰箱和冰櫃市場預計將達到17億美元。該行業的成長取決於先進的生物醫學冷凍和冷凍解決方案，這對於溫度敏感產品的正確儲存至關重要，從而推動了該國市場的擴張。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業影響力
    • 成長動力
      • 政府對研究活動和臨床試驗的支持不斷增加
      • 生物醫學冰箱和冷凍庫的技術進步
      • 老年人口基數不斷增加
      • 進步增加了對生物製藥和器官移植的需求
    • 產業陷阱與挑戰
      • 大量本地企業提供價格實惠的翻新設備
      • 冰箱和冷凍庫釋放的氫氟碳化合物對環境產生有害影響
      • 生物醫學冰箱和冰櫃的採購成本、維護成本和能源成本較高
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 定價分析，2021 - 2032
  • 成本結構分析
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

  • 主要趨勢
  • 等離子冷凍機
  • 血庫冰箱
  • 實驗室冰箱
  • 實驗室冰櫃
  • 超低溫冷凍櫃
  • 冷凍櫃

第 6 章：市場估計與預測：依最終用途，2021 - 2032 年

  • 主要趨勢
  • 血庫
  • 藥局
  • 醫院
  • 研究實驗室
  • 診斷中心
  • 其他最終用戶

第 7 章：市場估計與預測：按地區分類，2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 8 章：公司簡介

  • Aegis Scientific, Inc.
  • Azbil Corporation
  • B Medical Systems
  • BINDER GmbH
  • Eppendorf SE
  • Follett Products, LLC
  • Helmer Scientific Inc.
  • Lab Research Products
  • Migali Scientific
  • NuAire, Inc.
  • PHC Corporation
  • Powers Scientific, Inc.
  • So-Low Environmental Equipment Co.
  • Stirling Ultracold
  • Thermo Fisher Scientific Inc.
簡介目錄
Product Code: 822

The Global Biomedical Refrigerators And Freezers Market was valued at approximately USD 3.7 billion in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2032, driven by the rising geriatric population.

The World Health Organization (WHO) forecasts that by 2030, one in six people worldwide will be aged 60 or older. With an aging global populace comes an escalating demand for medical services, pharmaceuticals, and biopharmaceuticals tailored for the elderly. This demographic often requires comprehensive medical treatments, from vaccines and medications to organ transplants, underscoring the necessity of biomedical refrigerators and freezers for optimal storage and preservation. Moreover, the uptick in age-related diseases and conditions fuels advanced research and development in geriatric care, amplifying the demand for top-tier storage solutions in biomedical contexts.

Technological innovations are consistently augmenting the capabilities of biomedical refrigerators and freezers. Breakthroughs like enhanced cooling technologies, energy-efficient systems, and sophisticated temperature monitoring and control features have broadened the functionality and dependability of these devices. Additionally, the surging demand for biopharmaceuticals and organ transplants propels the market. Biotechnology advancements have escalated the production of biopharmaceuticals, including vaccines and gene therapies, which demand meticulous temperature regulation. Concurrently, the escalating need for organ transplants underscores the importance of dependable storage for donor organs. This heightened dependence on biopharmaceuticals and organ transplants amplifies the demand for state-of-the-art biomedical refrigeration systems, driving market expansion.

The overall biomedical refrigerators and freezers industry is classified based on product, end use , and region.

The lab refrigerators segment is projected to hit USD 1.6 billion by 2032. The surging demand for lab refrigerators stems from the increasing need to accurately store biological samples, reagents, and other temperature-sensitive materials vital for research and diagnostics. As global research activities burgeon and laboratories embrace technological advancements, the demand for dependable and efficient refrigeration solutions intensifies. The uptick in funding for academic and industrial research, coupled with a heightened focus on precision medicine and biotechnology, further amplifies the need for sophisticated lab refrigeration equipment. Additionally, the continuous evolution of features like superior temperature control, energy efficiency, and intuitive interfaces caters to the modern laboratory's demands.

The diagnostic centers segment recorded a valuation of USD 1.4 billion in 2023. These centers, which conduct a variety of tests for medical diagnoses, heavily depend on biomedical refrigeration and freezing equipment for storing delicate biological samples, reagents, and pharmaceuticals. The rising incidence of chronic diseases and the heightened demand for timely and precise diagnostics have spurred the need for cutting-edge diagnostic technologies and reliable storage solutions. Furthermore, the growing emphasis on preventive healthcare and routine health screenings has amplified the demand for these devices in diagnostic centers. As these centers evolve and broaden their offerings, the appetite for specialized biomedical refrigerators and freezers is poised to remain robust.

The U.S. biomedical refrigerators and freezers market is on track to reach USD 1.7 billion by 2032. As a front-runner in the global biopharmaceutical arena, the U.S. excels in developing and manufacturing vaccines, biologics, and cutting-edge therapies. The growth of this sector hinges on advanced biomedical refrigeration and freezing solutions, essential for the proper storage of temperature-sensitive products, thus driving market expansion in the nation.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry impact forces
    • 3.1.1 Growth drivers
      • 3.1.1.1 Rising government support for research activities and clinical trials
      • 3.1.1.2 Technological advancements in biomedical refrigerators and freezers
      • 3.1.1.3 Increasing geriatric population base
      • 3.1.1.4 Advances increasing demand for biopharmaceuticals and organ transplantation
    • 3.1.2 Industry pitfalls and challenges
      • 3.1.2.1 Presence of large number of local players providing affordable refurbished equipment
      • 3.1.2.2 Release of hydrofluorocarbons from refrigerators and freezers have deleterious impact on environment
      • 3.1.2.3 High purchase costs, maintenance costs and energy costs of biomedical refrigerators and freezers
  • 3.2 Growth potential analysis
  • 3.3 Regulatory landscape
  • 3.4 Technological landscape
  • 3.5 Pricing analysis, 2021 - 2032
  • 3.6 Cost structure analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Plasma freezers
  • 5.3 Blood bank refrigerators
  • 5.4 Lab refrigerators
  • 5.5 Lab freezers
  • 5.6 Ultra-low temperature freezers
  • 5.7 Shock freezers

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Blood banks
  • 6.3 Pharmacies
  • 6.4 Hospitals
  • 6.5 Research labs
  • 6.6 Diagnostic centers
  • 6.7 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Netherlands
    • 7.3.7 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Aegis Scientific, Inc.
  • 8.2 Azbil Corporation
  • 8.3 B Medical Systems
  • 8.4 BINDER GmbH
  • 8.5 Eppendorf SE
  • 8.6 Follett Products, LLC
  • 8.7 Helmer Scientific Inc.
  • 8.8 Lab Research Products
  • 8.9 Migali Scientific
  • 8.10 NuAire, Inc.
  • 8.11 PHC Corporation
  • 8.12 Powers Scientific, Inc.
  • 8.13 So-Low Environmental Equipment Co.
  • 8.14 Stirling Ultracold
  • 8.15 Thermo Fisher Scientific Inc.